Some tumours have a compromised ability to repair dsDNA breaks by homologous recombination, such as those with mutations in the tumour-suppressor genes BRCA1 and BRCA2. Blockade of BER by PARP inhibition results in an accumulation of dsDNA breaks which are lethal in these cells. The gene discussed is PARP1; the disease is neoplasm.